Tag: Vemlidy

Explore our medication guides and pharmacology articles within this category.

What are the benefits of VEMLIDY? A closer look at chronic hepatitis B treatment

Oct 9, 2025 •

4 min read

According to the World Health Organization, over 290 million people worldwide are living with chronic hepatitis B (HBV), a potentially life-threatening liver infection. For those with compensated liver disease, VEMLIDY (tenofovir alafenamide, or TAF) offers a targeted and highly effective treatment option, with several key benefits, particularly in comparison to older-generation antivirals.

Why is Vemlidy better than Viread? A detailed comparison

Oct 7, 2025 •

4 min read

Clinical trials have shown that Vemlidy (tenofovir alafenamide, TAF) provides similar antiviral efficacy to Viread (tenofovir disoproxil fumarate, TDF) for chronic hepatitis B at a dose less than one-tenth that of Viread. This significant difference in dosage efficiency and safety profile is at the heart of the question: why is Vemlidy better than Viread?